Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference Feb 24, 2026 07:00AM
Dianthus Therapeutics to Participate in Four Investor Conferences During November Nov 4, 2025 08:00AM
TD Cowen on Dianthus (DNTH): 'the favorable economics of the deal will not impact prior guidance of cash runway into 2028' Oct 16, 2025 09:57AM
Dianthus Therapeutics closes $288 million public offering Sep 11, 2025 04:07PM
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Sep 11, 2025 04:07PM


Sep 9, 2025 10:35PM Dianthus Therapeutics prices $251 million public offering at $33 per share
Sep 9, 2025 10:35PM Dianthus Therapeutics, Inc. Announces Pricing of Upsized $251 Million Underwritten Public Offering
Sep 8, 2025 04:00PM Dianthus Therapeutics announces $150 million public offering
Sep 8, 2025 04:00PM Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
Feb 26, 2025 07:00AM Dianthus Therapeutics to Participate in Two Upcoming Investor Conferences
Dec 20, 2024 05:31AM TD Cowen Starts Dianthus Therapeutics (DNTH) at Buy